Entera Bio appoints ex-Gilead executive Laura Hamill to board of directors
ENTX•Entera Bio named former Gilead executive Laura Hamill to its board, effective Dec. 1, 2026. Hamill has more than 35 years of global commercial leadership experience and most recently ran Gilead’s worldwide commercial operations; she replaces Yonatan Malca, who is stepping down.
1. Board appointment
Entera Bio named former Gilead executive Laura Hamill to its board, effective Dec. 1, 2026. She replaces Yonatan Malca, who is stepping down from the board.
2. Hamill’s experience
Hamill brings more than 35 years of global commercial leadership experience. Most recently, she ran Gilead’s worldwide commercial operations.
